A new study from Hong Kong has found that, despite clinical trials claiming otherwise, weight loss rarely sends type 2 diabetes into remission in real-world settings.
The Food and Drug Administration is investigating reports of side effects from GLP-1 drugs like Ozempic and Wegovy, including suicidal ideation and hair loss. A large new study found no link between semaglutide, the active ingredient in some GLP-1 drugs, and suicidal ideation.